Abstract
The main pathology associated with Schistosomiasis mansoni is granulomatous inflammation that may develop into hepatosplenic disease with fibrosis and hepatoesplenomegaly. It is known that N-acetyl-L-cysteine (NAC) reduces tissue damage in chronic liver diseases owing to its anti-inflammatory, antioxidant, and detoxifying properties. In this study, we investigated the imunohistopathological changes in murine schistosomiasis mansoni under the influence of NAC, in combination with Praziquantel (PZQ) or not. Three groups of mice were formed to evaluate the effects of NAC during infection in the acute, intermediate, and chronic phases. Each group was further subdivided into four subgroups: NAC, PZQ, NAC + PZQ and control (without treatment). Oral administration of NAC (200 mg/kg/day) was carried out on the first day after infection for the acute phase and on the 45th for the intermediate and chronic phases for 59 and 45, 75 days, respectively. PZQ (100 mg/kg/day), was given orally by gavage from the 45th to 49th day after infection. Histopathological analysis of liver tissue provided evidence that combined NAC + PZQ treatment reduced the development of granulomas observed in the chronic phase. Animals treated with NAC and/or PZQ showed a reduction in the size of granulomas and all those treated with NAC exhibited a lower degree of fibrosis. In all groups, NAC decreased the synthesis of interferon-γ and nitric oxide, while increasing the levels of interleukin-10, but it did not influence the production of interleukin-4. On the whole, NAC treatment induced an immunomodulatory effect and reduced liver damage during the granulomatous inflammation in S. mansoni-infected mice.
Similar content being viewed by others
References
Abdul-Ghani RA, Loutfy N, Hassan A (2009) Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use. Parasitol Res 105:899–906
Albuquerque MCPA, Silva TG, Pitta MG, Silva AC, Silva PG, Malagueño E, Santana JV, Wanderley AG, Lima MC, Galdino SL, Barbe J, Pitta IR (2005) Synthesis and schistosomicidal activity of new substituted thioxo-imidazoline compounds. Die Pharmazie 60:13–17
Albuquerque MCPA, Pitta MG, Irmão JI, Peixoto CA, Malagueño E, Santana JV, Lima MC, Galdino SL, Pitta IR (2007) Tegumental alterations in adult Schistosoma mansoni treated with imidazolidine derivatives. Lat Am J Pharm 26:65–69
Andrade ZA (2005) Regressão da fibrose hepática. Rev Soc Bras Med Trop 38:514–520
Andrade ZA, Cheever AW (1993) Charecterization of the murine modelo schistosomal hepática periportal fibrosis (“pipestem” fibrosis). Int J Exp Pathol 74:95–202
Bina JC, Prata A (2003) Esquistossomose na área hiperendêmica de Taquarendi: Infecção pelo Schistosoma mansoni e formas graves. Rev Soc Bras Med Trop 36:211–216
Blanchard TJ (2004) Schistosomiasis. Travel Med Infect Dis 2:5–11
Capron AR, Dessaint JP, Capron M, Pearce RJ (1992) Schistosomiasis: from effector and regulation mechanisms in rodents to vaccine strategies in humans. Immunol Investig 21:409–422
Chitsulo L, Engels D, Montresor A, Savioli L (2000) The global status of schistosomiasis and its control. Acta Trop 77:41–45
Cioli D, Botro SS, Wheatcroft-Francklow K, Mbaye A, Southgate V, Tchuente LAT, Pica-Mattoccia L, Troiani AR, Seifel-Din SH, Sabra ANA, Albin J, Engels D, Doenhoff MJ (2004) Determination of ED50 values for praziquantel in praziquantel-resistant and-susceptible Schistosoma mansoni isolates. Int J Parasitol 34:979–987
Coutinho EM, Silva FL, Barros AF, Araújo LE, Oliveira SA, Luna CF, Barbosa AAJ, Andrade ZA (2007) Repeated infections with Schistosoma mansoni and liver fibrosis in undernourished mice. Acta Trop 101:15–24
Doenhoff MJ, Kusel JR, Coles GC, Cioli D (2002) Resistance of Schistosoma mansoni to praziquantel: is there a problem? Trans R Soc Trop Med Hyg 96:465–469
Fallon PG, Richardson EJ, McKenzie GJ, McKenzie AN (2000) Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 164:2585–2591
Fan ZG, Zhang LM, Li KJ, Li W, Zhu PX, Yang G (2007) Effect of N-acetylcysteine on the egg granuloma in hepatic tissue of mice with schistosomiasis japonica. Chin J Parasitol Parasit Dis 25:137–140
Gharib B, Abdallahi OM, Dessein H, De Reggi M (1999) Development of eosinophil peroxidase activity and concomitant alteration of the antioxidant defenses in the liver of mice infected with Schistosoma mansoni. J Hepatol 30:594–602
Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131–138
Gryzch JM, Pearce EJ, Cheever AW, Caulada ZA, Caspar P, Hieny S, Lewis A, Sher A (1991) Egg deposition is a major stimulus for the production of Th2 cytokines in murine Schistosomiasis mansoni. J Immunol 146:1322–1327
Halliwell B, Gutteridge J (2007) Free radicals in biology and medicine, 4th edn. University Press, Oxford
Hang LM, Warren KS, Boros DL (1974) Schistosoma mansoni: antigenic secretions and the etiology of egg granulomas in mice. Exp Parasitol 35:288–298
Hardman JG, Limbird LE, Gilman AG (2001) Goodman and Gilman's The pharmacological basis of therapeutics, 10th edn. McGraw Hill, New York
Herbert DR, Orekov T, Perkins C, Finkelman R (2008) IL-10 and TGF redundantly protect against severe liver injury and mortality during acute schistosomiasis. J Immunol 181:7214–7220
Hoffmann KF, Cheever AW, Wynn TA (2000) IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses incuse distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 164:6406–6416
Ismail M, Botros S, Metwally A, William S, Farghally A, Tao LF, Day TA, Ben-Nett JL (1999) Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. AmJTrop Med Hyg 60:932–935
Jones AL, Bangash IH, Bouchier IAD, Hayes PC (1994) Portal and systemic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis. Gut 35:1290–1293
Joseph S, Jones FM, Walter K, Fulford AJ, Kimani G, Mwatha JK, Kamau T, Kariuki HC, Kazibwe F, Tukahebwa E, Kabatereine NB, Ouma JH, Vennervald B, Dunnel DW (2004) Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel. J Infect Dis 190:835–842
Kazura JW, Brito P, Rabbege J, Aikawa M (1985) Role of granulocyte oxygen products in damage of Schistosoma mansoni eggs in vitro. J Clin Invest 75:1297–1307
Kelly GS (1998) Clinical applications of N-acetylcysteine. Altern Med Rev 3:114–127
Lauz S, Nigro AJ, Taha MO, Montero EFS, Junqueira V, Gomes L, Ramalho C (2000) Estudo da preservação do fígado utilizando-se um anti-oxidante: N-acetilcisteína. Acta Cir Bras 15(Suppl 1):43
Liang YS, Coles GC, Doenhoff MJ, Southgate VR (2001) In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel. Int J Parasitol 31:1227–1235
Magalhães LG, Machado CB, Morais ER, Moreira EBC, Soares CS, Silva SH, Filho AAS, Rodrigues V (2009) In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitol Res 104:1197–1201
Magalhães LG, Kapadia GJ, Tonuci LRS, Caixeta SC, Parreira NA, Rodrigues V, Filho AAS (2010) In vitro schistosomicidal effects of some phloroglucinol derivatives from Dryopteris species against Schistosoma mansoni adult worms. Parasitol Res 106:395–401
Morel F, Doussere J, Vignais PV (1991) The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects. Eur J Biochem 201:523–546
Nare B, Smith JM, Prichard RK (1990) Schistosoma mansoni: levels of antioxidants and resistance to oxidants increase during development. Exp Parasitol 70:389–397
Oliver L, Stirewalt MA (1952) An efficient method for exposure of mice to cercariae of Schistosoma mansoni. J Parasitol 38:19–23
Pearce EJ, Macdonald AS (2002) The immunobiology of Schistosomiasis. Nat Rev Immunol 7:499–511
Pereira-Filho G, Ferreira C, Schwengber A, Marroni C, Zettler C, Marroni N (2008) Role of N-acetylcysteine on fibrosis and oxidative stress in cirrhotic rats. Arq Gastroenterol 45:156–162
Pica-Mattoccia L, Cioli D (2004) Sex and stage related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int J Parasitol 34:527–533
Pinho RA, Silveira PC, Silva LA, Luiz-Streck E, Dal-Pizzol F, Moreira FC (2005) N-Acetylcysteine and deferoxamine reduce pulmonary oxidative stress and inflammation in rats after coal dust exposure. Environ Res 99:355–360
Poli G, Parola M (1997) Oxidative damage and fibrogenesis. Free Radic Biol Med 22:287–305
Segawa M, Kayano K, Sakaguchi I, Okamoto M, Sakaida I, Okita K (2002) Antioxidant, N-acetyl-L-cysteine inhibits the expression of the collagen α2 (I) promoter in the activated human hepatic stellate cell line in the absence as well as the presence of transforming growth factor-β. Hepatol Res 24:305–315
Seif el-Din SH, Al-Hroob AM, Ebeid FA (2011) Schistosoma mansoni: N-acetylcysteine downregulates oxidative stress and enhances the antischistosomal activity of artemether in mice. Exp Parasitol 128:230–235
Smithers SR, Terry RJ (1965) The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 55:695–700
Vincenzini MT, Favilli F, Iantomasi T (1998) Glutathione-mediated transport across intestinal brush-border membranes. Biochim Biophys Acta 942:107–114
Wynn TA, Eltoum I, Cheever AW, Lewis FA, Gause WC, Sher A (1993) Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol 151:1430–1440
Yang YY, Lee KC, Huang YT, Wang YW, Hou MC, Lee FY, Lin HC, Lee SD (2008) Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis. J Hepatol 49:25–33
Zafarullah M, Li WQ, Sylvester J, Ahmad M (2003) Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 60:6–20
Acknowledgments
This work received financial support fron the Fundação de Amparo à Pesquisa de Pernambuco (FACEPE) and Universidade Federal de Pernambuco (UFPE).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Lima Aires, A., de Azevedo Albuquerque, M.C.P., Silva, R.A.R. et al. Immunohistopathological changes in murine Schistosomiasis mansoni under the influence of N-acetyl-L-cysteine. Parasitol Res 111, 1569–1578 (2012). https://doi.org/10.1007/s00436-012-2997-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-012-2997-4